Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kushner

Showing results (151-160 of 245) with videos related to

Pageof 25
Sort By:
Pediatric Blood & Cancer|June 24, 2025
Pulmonary Toxicity Associated With Concurrent Lorlatinib and Anti-GD2 Monoclonal Antibody Therapy in Patients With NeuroblastomaWei Wei, Maggie Eidson Fader, Brian H Kushner, et al.
Pediatric Blood & Cancer|January 28, 2021
Mandibular metastases in neuroblastoma: Outcomes and dental sequelaeAnnu Singh, Shakeel Modak, Armand K Solano, et al.
Pediatric Blood & Cancer|February 23, 2018
Dose-escalation is needed for gross disease in high-risk neuroblastomaDana L Casey, Brian H Kushner, Nai-Kong V Cheung, et al.
Pediatric Blood & Cancer|June 17, 2020
Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experienceAmi Patel, Cheryl Fischer, Yi-Chih Lin, et al.
Medical and Pediatric Oncology|February 9, 1999
Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosisP Cole, M Ladanyi, W L Gerald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remissionNai-Kong V Cheung, Irene Y Cheung, Brian H Kushner, et al.
Vaccines|June 27, 2024
Long Prime-Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer VaccineIrene Y Cheung, Audrey Mauguen, Shakeel Modak, et al.
Journal of Pediatric Surgery|August 1, 1994
Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcomeM P La Quaglia, B H Kushner, G Heller, et al.
Oncoimmunology|November 18, 2017
Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survivalIrene Y Cheung, Brian H Kushner, Shakeel Modak, et al.
Cancer|July 15, 1991
High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastomaB H Kushner, S C Gulati, J H Kwon, et al.
Pageof 25

Showing results (151-160 of 245) with videos related to

Sort By:
Pageof 25
Pediatric Blood & Cancer|June 24, 2025
Pulmonary Toxicity Associated With Concurrent Lorlatinib and Anti-GD2 Monoclonal Antibody Therapy in Patients With NeuroblastomaWei Wei, Maggie Eidson Fader, Brian H Kushner, et al.
Pediatric Blood & Cancer|January 28, 2021
Mandibular metastases in neuroblastoma: Outcomes and dental sequelaeAnnu Singh, Shakeel Modak, Armand K Solano, et al.
Pediatric Blood & Cancer|February 23, 2018
Dose-escalation is needed for gross disease in high-risk neuroblastomaDana L Casey, Brian H Kushner, Nai-Kong V Cheung, et al.
Pediatric Blood & Cancer|June 17, 2020
Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experienceAmi Patel, Cheryl Fischer, Yi-Chih Lin, et al.
Medical and Pediatric Oncology|February 9, 1999
Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosisP Cole, M Ladanyi, W L Gerald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remissionNai-Kong V Cheung, Irene Y Cheung, Brian H Kushner, et al.
Vaccines|June 27, 2024
Long Prime-Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer VaccineIrene Y Cheung, Audrey Mauguen, Shakeel Modak, et al.
Journal of Pediatric Surgery|August 1, 1994
Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcomeM P La Quaglia, B H Kushner, G Heller, et al.
Oncoimmunology|November 18, 2017
Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survivalIrene Y Cheung, Brian H Kushner, Shakeel Modak, et al.
Cancer|July 15, 1991
High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastomaB H Kushner, S C Gulati, J H Kwon, et al.
Pageof 25